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Abstract
Successful implementation of left ventricular assist devices lead to a prolonged survival in patients with chronic terminal heart
failure. Thus, patients with pre-existing left ventricular assist devices with abdominal comorbidities requiring abdominal
surgery, e.g. for malignancy, are upcoming issues. We carried out a major liver resection for hepatocellular carcinoma in a
patient with pre-existing left ventricular assist device. The importance of this case report is that it outlines the significance
of oncologic resections in patients with left ventricular assist devices as an upcoming issue and provides an interdisciplinary
approach.
INTRODUCTION
In chronic heart failure left ventricular assist devices (LVADs) are
a well-established option [1]. In our centre 110–130 devices are
implanted every year. Leading to a prolonged survival, comor-
bidities requiring abdominal surgery, e.g. oncologic resections,
are upcoming issues.
CASE REPORT
A 64-year-old male with severe ischemic cardiomyopathy under-
went implantation of an LVAD (Heart mate IITM, Abbott, Chicago,
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USA) in 2012. Decision of LVAD as destination therapy instead
of heart transplantation was made due to history of hepati-
tis B infection, chronic kidney insufficiency and COPD. Patient
remained in good condition with normal LVAD function. Further
history included atrial fibrillation and pulmonary embolism. In
2019, hepatocellular carcinoma (HCC) was incidentally detected
in the postero-lateral sector of the liver. Preoperative LiMax-
Test [2] revealed good liver function (316 μ/kg/h), MELD XI Score
was 15 without signs of portal hypertension. Staging revealed
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Figure 1: Preoperative CT scan revealing suspected malignancy
Anticoagulation was performed with Vit K antagonists and
one episode of LVAD partial thrombosis appeared in 2015. The
patient was admitted 3 days prior to surgery allowing conver-
sion to full heparinization with target aPTT prior to surgery, on
postoperative day (POD) 1, 2 and 3 set as: 55–60 s; 45–50 s; 50–55 s
and 55–65 s.
Because driveline was located in the way of planned laparo-
tomy, surgery was scheduled as an interdisciplinary approach.
After right transverse and combined median laparotomy dur-
ing which the driveline was identified, exploration of the abdom-
inal cavity ruled out extrahepatic tumour spread. An intraoper-
ative ultrasound confirmed local resectability.
LVAD-driveline was then dissected from scarring tissue, dis-
connected from its controller for 30 s and repositioned in the
left upper quadrant. Circulation was maintained with the use
of epinephrine and norepinephrine. Figure 2a and b show pre-
operative and postoperative driveline positions. Figure 2c shows
relocated driveline position and former driveline exit.
Liver resection was performed via ‘pedicle approach’. After
mobilization of the right hepatic lobe with posterior transection
of Makuuchis ligament and preparation of the right hepatic
vein, the vein was encircled with a loop and hilar preparation
followed: after lowering the hilar plate, the right and left
glissonean pedicle were identified. Right pedicle was followed
until its branching into antero-medial and postero-lateral
pedicles. Safety clamping of the posterolateral branch with
sonography of the antero-medial branch was performed leading
to a clear demarcation of the now ‘in-flow’ devascularized
postero-lateral sector. Parenchymal transection was performed
using CUSATM (Cavitron Ultrasonic Surgical Aspirator, Valleylab
Boulder, CO, USA) starting at the right hepatic vein and
continuing alongside the border of segments VII/VI and VIII/V.
Crossing structures were clipped or ligated with titan clips and
3–0 or 4–0 Vicryl TM. Pringle manoeuvre was used twice for a
maximum of 15 min, interrupted by at least 5 min reperfusion.
Finally, only the posterolateral pedicle and the right liver
vein remained and were selectively clamped, dissected and
oversewed (Fig. 3a).
After rinsing and meticulous control for bleeding and bile
leaks, drains were placed and an omental flap was prophy-
lactically attached ibidem. The retrieved specimen is shown in
Fig. 3b.
Postoperatively, the patient was admitted to the cardiosur-
gical intensive care unit. LVAD flow was over 5 l/min and no
further use of vasopressors was necessary. After on POD 6 the
former drainage exit started purulent secretion and a computed
tomography (CT) scan revealed a small bilioma, an ERCP was
performed. A bile leakage type B (ISGLS) was diagnosed and
treated by stenting of the common bile duct. Concomitantly, a
transient acute on chronic kidney insufficiency (AKIN ◦I) was
diagnosed and conservatively managed. The patient was trans-
ferred to our surgical ward on POD 10 without signs of systemic
infection. A superficial surgical site infection underwent conser-
vative treatment. In postoperative quality management analysis
the case was classified Clavien-Dindo ◦IIIa and SSI ◦I. Both liver
and LVAD function remained satisfactory. Oral anticoagulation
was reestablished and the patient was discharged on POD 19.
Histopathology confirmed the diagnosis of HCC (pT4 G2 R0 L0
V0 Pn0 M0, 8th TNM classification).
Six weeks after surgery the bile duct stent was removed
without complications.
The case was discussed in our interdisciplinary Hepato-
Pancreato-Biliary (HPB) tumour conference and regular oncologic
surveillance was recommended. After 6 months, the patient
presented a good general condition and imaging showed no sign
of local or distant recurrence.
DISCUSSION
Conditional on initial survival, long-term survival after LVAD
implantation is possible [3]. This leads to more patients concomi-
tantly requiring abdominal tumour surgery. HCC is a serious life
threat and since the patient was in good general condition, an
interdisciplinary approach was made to evaluate risk factors. To
the best of our knowledge, there has no case of complex major
liver surgery been reported in these patients previously. Elective
abdominal surgery for patients with LVAD requires a special-
ized team and sufficient preoperative preparation. Relocation of
the driveline may become necessary. Lower abdominal surgery
requiring an infraumbilical median laparotomy often does not
interfere with the driveline [4]. Exposure of the surgical site often
requires retractors, which may interfere with the LVAD cannulas
[5]. LVAD furthermore contributes a pulseless blood flow and
microperfusion may be affected. Furthermore, continuous flow
instead of pulsatile flow was described to harden the identifica-
tion and palpation of vascular structures [5]. In our case, vascular
structures were identified by subtle preparation (extrafascial
pedicle and combined venous first approach) and confirmed by
the use of intraoperative ultrasound.
At our centre the usual approach to postero-lateral sectionec-
tomy is minimal invasive (laparoscopic or robotic-assisted). In
the presented case we decided to perform an open approach,
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Figure 2: (a and b) LVAD and driveline in preoperative and postoperative CT scan scout. (c) Relocated driveline during laparotomy, forceps in former driveline exit.
Figure 3: (a) Liver after parenchymal dissection showing the relocated driveline, the postero-lateral pedicle and the right hepatic vein. (b) Macroscopic view on tumour
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might not have been possible. Regardless of choosing laparotomy
or laparoscopy, awareness of the driveline-position is essen-
tial. Meticulous preoperative evaluation of comorbidities and
treatment strategies is mandatory to tailor an individualized
strategy.
CONCLUSION
In patients with LVAD and concomitant liver malignoma ade-
quately prepared and scheduled surgery with interdisciplinary
management may be a feasible treatment option. These patients
should be presented to experienced centres’ HPB tumour boards
rather than upfront indicating palliative therapy.
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